THE HYPERTENSION PREVENTION TRIAL - ASSESSMENT OF THE QUALITY OF BLOOD-PRESSURE MEASUREMENTS

被引:62
作者
CANNER, PL
BORHANI, NO
OBERMAN, A
CUTLER, J
PRINEAS, RJ
LANGFORD, H
HOOPER, FJ
机构
[1] MARYLAND MED RES INST,BALTIMORE,MD
[2] UNIV CALIF DAVIS,DEPT COMMUNITY HLTH,DAVIS,CA 95616
[3] UNIV ALABAMA,DEPT PREVENT MED,BIRMINGHAM,AL 35294
[4] NHLBI,DIV EPIDEMIOL & CLIN APPLICAT,BETHESDA,MD 20892
[5] UNIV MINNESOTA,SCH PUBL HLTH,DIV EPIDEMIOL,MINNEAPOLIS,MN 55455
[6] UNIV MISSISSIPPI,DEPT MED,JACKSON,MS 39216
关键词
BLOOD PRESSURE DETERMINATION; CLINICAL TRIALS; EPIDEMIOLOGIC METHODS; HYPERTENSION; QUALITY CONTROL;
D O I
10.1093/oxfordjournals.aje.a116100
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Blood pressure variability is an important consideration in hypertension trials for determining required sample size and consequently making accurate outcome statements. The Hypertension Prevention Trial was a randomized controlled trial carried out in 1983-1986 in four US clinics on men and women with high normal diastolic blood pressure. This trial provided an opportunity to assess conditions affecting blood pressure measurement variability. Trained blood pressure observers measured systolic and diastolic blood pressures twice, 30 seconds apart, using a random-zero sphygmomanometer. The quality of blood pressure measurements was assessed by computing the variability of the two readings per participant-visit for each blood pressure observer at each study clinic. Other sources of variability investigated included observer digit preference, time of day, and ambient temperature. On the basis of data from this population, it is estimated that the standard deviation of blood pressure values can be reduced by 5% by taking two measurements per participant-visit. An additional reduction of variability can be effected by having the duplicate blood pressure measurements made by different blood pressure observers. In special instances where the range of blood pressure values is very restricted, use of the random-zero sphygmomanometer can increase or decrease the among-participant variability in blood pressure values, depending upon where the distribution of blood pressure values is centered.
引用
收藏
页码:379 / 392
页数:14
相关论文
共 22 条
  • [1] ARMITAGE P, 1966, CLIN SCI, V30, P325
  • [2] ARMITAGE P, 1966, CLIN SCI, V30, P337
  • [3] EXTERNAL QUALITY-CONTROL PROGRAMS
    CANNER, PL
    KROL, WF
    FORMAN, SA
    [J]. CONTROLLED CLINICAL TRIALS, 1983, 4 (04): : 441 - 466
  • [4] DISCHINGER P, 1986, CONTROL CLIN TRIALS, V7, pS137
  • [5] Engel P., 1974, BIORHYTHMS HUMAN REP, P325
  • [6] SOME EFFECTS OF WITHIN-PERSON VARIABILITY IN EPIDEMIOLOGICAL-STUDIES
    GARDNER, MJ
    HEADY, JA
    [J]. JOURNAL OF CHRONIC DISEASES, 1973, 26 (12): : 781 - 795
  • [7] GAUER OTTO H., 1965, HANDBOOK PHYSIOL, V3, P2409
  • [8] DESIGN OF BLOOD-PRESSURE SCREENING FOR CLINICAL-TRIALS OF HYPERTENSION
    GOLDMAN, A
    [J]. JOURNAL OF CHRONIC DISEASES, 1976, 29 (10): : 613 - 624
  • [9] WITHIN-PERSON VARIABILITY IN DIASTOLIC BLOOD-PRESSURE FOR A COHORT OF NORMOTENSIVES
    HEBEL, JR
    APOSTOLIDES, AY
    DISCHINGER, P
    ENTWISLE, G
    SU, S
    [J]. JOURNAL OF CHRONIC DISEASES, 1980, 33 (11-1): : 745 - 750
  • [10] Hypertension Prevention Trial Research Group, 1990, ARCH INTERN MED, V150, P153, DOI [10.1001/archinte.1990.00390130131021, DOI 10.1001/ARCHINTE.1990.00390130131021]